MDedge Cardiocast
MDedge Cardiocast is the weekly podcast from Cardiology News. The information in this podcast is provided for informational and educational purposes only.
Episodes
ISCHEMIA trial hailed as practice changing
The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves.
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics
Further analyses from the DAPA-HF trial showed dapagliflozin cut death and heart failure events in HFrEF patients with no diabetes.
Colchicine cut post-MI CVD events
Colchicine fulfilled the promise first ...
Vascepa approved for cardiovascular risk reduction
The FDA’s decision on cutting events in high-risk patients was based primarily on the REDUCE-IT trial.
ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding
Novel oral anticoagulants may be preferred over warfarin in patients with diabetes and AFib.
HHS drug importation proposals aim to address high costs
Trump administration drops key health care proposa...
Women have fewer cardiovascular events after non–ST-segment elevation ACS
But they also remain undertreated with guideline-directed therapies.
* * *
Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019
* * *
Icosapent ethyl cost effective in REDUCE-IT analysis
Treatment with the fish-derived drug Vascepa for CV event reduction is more effective and less costly than placebo.
* * *
Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019
* * *
This week’s Cardiocast is devoted entirely to Card Talk with cardiologist brothers Jim and Jerry Dwyer. They welcome two structural interventionalists at the Structural Heart and Valve Center at Emory Healthcare, Kendra J. Grubb, MD, and Isida Byku, MD. Both followed a unique track, training in both cardiac surgery and interventional cardiology and practicing in the fast-moving field of structural heart disease.
In this special meeting edition of the Cardiocast, MDedge Cardiology editor Catherine Hackett is joined by MDedge reporters Mitchel L. Zoler, Bruce Jancin, and Richard Mark Kirkner.
The MDedge cardiology team reviews three big stories from the 2019 annual scientific sessions of the American Heart Association in Philadelphia.
* * *
ISCHEMIA trial hailed as practice changing
The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves.
* * *
Help us make this podcast better!
Getting high heightens stroke, arrhythmia risks
Cannabis use or abuse among the young was associated with adverse cardiovascular consequences in two studies.
* * *
Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019
* * *
Closing the missing link between childhood risk factors and adult cardiovascular outcomes
Prescient childhood cohort studies launched in the 1970s are paying off.
* * *
Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019
* * *
Patients frequently drive too soon after ICD implantation
Many patients didn’t recall ever receiving instruction about when to drive again.
* * *
Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019
* * *
One-third of CVD disease in blacks linked to hypertension
A large analysis suggests interventi...
Strong showing for TAVR after 5 years in PARTNER 2A
Transcatheter and surgical aortic valve replacement had similar rates of death or disabling stroke.
* * *
Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019
* * *
Patiromer allows more CKD patients to continue on spironolactone
After 12 w...
MDedge reporters discuss the latest in practice-changing data from the 2019 annual congress of the European Society of Cardiology in Paris.
Join Mitchel L. Zoler, Bruce Jancin, Kari Oakes, and MDedge Cardiology editor Catherine Hackett as they discuss what they reported from the annual meeting.
Statin use linked to risk of skin and soft tissue infections
Use of statins was associated with increased risk of SSTIs at an average of 91, 182, and 365 days.
Rivaroxaban trends toward higher thrombotic risk than vitamin K antagonists in APS
Patients who took rivaroxaban experienced almost two times as many thrombotic events as patients who took dose-adjusted vitamin K antagonists.
Novel cardiac troponin protocol rapidly rules out MI
Three-quarters of patients who presented with suspected acute coronary syndrome were safely discharged from ED without hospital admission.
Study questions preemptive TEVAR for extended type A dissections
Interim results from a single-center study show that preemptive TEVAR may not be necessary for type A aortic dissections.
TAVR, SAVR share same infective endocarditis risk
Be ...
Smoking and inactivity are the most powerful lifestyle risk factors after an MI
Insufficient activity beats out obesity or above-target LDL cholesterol.
Ticagrelor monotherapy tops DAPT for high-risk PCI patients
TWILIGHT findings support move to shorter dual-antiplatelet therapy.
Panel releases guidelines for red meat, processed meat consumption
"This assessment may be excessively pessimistic; indeed, we hope that is the case."
...Cardiology dead last as women’s IM subspecialty choice
Women in internal medicine residencies were more likely than men to report that they had never considered cardiology as a career choice.
Beta-blockers effective, safe for HFrEF with renal dysfunction
Their role is solidified for essentially all such heart failure patients, regardless of their renal function.
Heart failure score derived from machine learning predicts risk in ...
Prasugrel bests ticagrelor in ACS in surprise findings
ISAR-REACT 5 was the first-ever direct head-to-head look at two potent P2Y12 inhibitors in this setting.
European cholesterol guidelines push LDL targets below 55 mg/dL
PCSK-9 inhibitors are elevated to a top-tier recommendation in very-high-risk patients.
Drug doses for heart failure could possibly be halved for women
Women reached the highest level of drug efficacy at half...
MDedge reporters discuss the latest in practice-changing data from the 2019 annual congress of the European Society of Cardiology in Paris.
Join Mitchel L. Zoler, Bruce Jancin, Kari Oakes, and MDedge Cardiology editor Catherine Hackett as they discuss what they reported from the annual meeting.
We introduce a brand new format with Jerome Dwyer, MD, brother of our host, Jim Dwyer, MD, for a new segment that we're calling 'Card Talk' where Dr. Jim and Dr. Jerry talk about the current clinical state of cardiology and take a peek into the future.
This week in cardiology news:
DAPA-HF results transform dapagliflozin from antidiabetic to heart failure drug
Read more
Popular Podcasts
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
The latest news in 4 minutes updated every hour, every day.
An unlicensed lizard psychologist travels the universe talking to strangers about absolutely nothing. TO CALL THE GECKO: follow me on https://www.twitch.tv/lyleforever to get a notification for when I am taking calls. I am usually live Mondays, Wednesdays, and Fridays but lately a lot of other times too. I am a gecko.
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.
Listen to 'The Bobby Bones Show' by downloading the daily full replay.